Clinic
Prisma Health-Upstate
Prisma Health-Upstate was paid $7.45M by Medicaid between Jan 2018 and Nov 2024, across 50 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 30% of everything it billed.
33Billing provider infoPRISMA HEALTH-UPSTATE
GREENVILLE, SC 29605
GREENVILLE, SC 29605
33aNPI1770039885assigned 08/29/2016
33bProvider typeInfusion Therapy Clinic/Center
28Total paid$7.45M
24GClaims92,739
24DCodes billed50
24AFirst – last monthJan 2018 – Nov 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MILLER, POLLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,890 | $372K | |
| 2019 | 13,220 | $963K | |
| 2020 | 14,670 | $1.51M | |
| 2021 | 13,204 | $1.10M | |
| 2022 | 13,255 | $1.25M | |
| 2023 | 16,778 | $1.20M | |
| 2024incomplete | 12,722 | $1.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 30% | 246 | 169 | $2.22M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 15% | 807 | 429 | $1.12M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 11% | 9,524 | 5,395 | $848K |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 9.0% | 464 | 266 | $672K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.3% | 5,889 | 3,899 | $317K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 3.0% | 298 | 198 | $225K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.6% | 9,516 | 5,053 | $193K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2.5% | 245 | 98 | $190K |
| 36430 | 2.4% | 1,181 | 807 | $182K | |
| 96417 | 1.7% | 2,309 | 1,295 | $130K | |
| J1453 | Injection, fosaprepitant, 1 mg | 1.6% | 1,707 | 975 | $119K |
| 96409 | 1.6% | 1,766 | 1,181 | $117K |
38 more codes
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1.6% | 523 | $117K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1.5% | 3,935 | $110K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 3,389 | $97K |
| J1756 | Injection, iron sucrose, 1 mg | 1.2% | 1,628 | $93K |
| 96367 | 1.2% | 3,229 | $93K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.2% | 3,021 | $92K |
| 96411 | 1.1% | 1,949 | $82K | |
| 96415 | 1.1% | 3,209 | $79K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,731 | $74K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,320 | $56K |
| J0185 | Injection, aprepitant, 1 mg | <1% | 369 | $52K |
| 96416 | <1% | 454 | $46K | |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | <1% | 29 | $44K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 643 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,901 | $10K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | <1% | 29 | $9K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 11,406 | $8K |
| C9463 | Injection, aprepitant, 1 mg | <1% | 23 | $6K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,180 | $5K |
| J9045 | Injection, carboplatin, 50 mg | <1% | 213 | $5K |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 717 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,470 | $3K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 176 | $3K |
| J9370 | Vincristine sulfate, 1 mg | <1% | 474 | $3K |
| J3490 | Unclassified drugs | <1% | 204 | $2K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 42 | $2K |
| 96368 | <1% | 135 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,124 | $2K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 96 | $941.17 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,419 | $844.25 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 20 | $632.89 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 319 | $574.04 |
| J9263 | Injection, oxaliplatin, 0.5 mg | <1% | 31 | $482.64 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 120 | $298.11 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 75 | $109.68 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 99 | $66.87 |
| J9250 | Methotrexate sodium, 5 mg | <1% | 23 | $45.33 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 62 | $28.24 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, POLLY (VP PAYOR STRATEGIES & ALIGNMENT)
| Provider | Location | Paid |
|---|---|---|
| Prisma Health-Midlands | Columbia, SC | $74.58M |
| Prisma Health-Midlands | Columbia, SC | $68.26M |
| Prisma Health-Upstate | Greenville, SC | $25.04M |
| Prisma Health-Upstate | Greenville, SC | $21.98M |
| Prisma Health-Upstate | Greenville, SC | $19.69M |
| Prisma Health-Upstate | Seneca, SC | $15.64M |
| Prisma Health-Midlands | Columbia, SC | $11.77M |
| Prisma Health-Upstate | Greenville, SC | $10.74M |
| Greenville Health Corporation | Greenville, SC | $8.90M |
| Prisma Health-Upstate | Greenville, SC | $8.32M |
| Prisma Health University Medical Group | Greenville, SC | $7.44M |
| Prisma Health-Midlands | Coulmbia, SC | $7.43M |
| Prisma Health-Midlands | Columbia, SC | $6.88M |
| Prisma Health Tuomey | Sumter, SC | $6.84M |
| Prisma Health-Midlands | Columbia, SC | $6.77M |
| Prisma Health-Upstate | Greenville, SC | $6.37M |
| Prisma Health-Upstate | Greenville, SC | $5.00M |
| Prisma Health-Upstate | Greenville, SC | $4.65M |
| Prisma Health-Midlands | Columbia, SC | $4.63M |
| Prisma Health-Upstate | Seneca, SC | $4.48M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.